Amount that if recognized, would affect the effective tax rate or regulatory liability
Vertex Pharmaceuticals Amount that if recognized, would affect the effective tax rate or regulatory liability decreased by 3.7% to $420.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.6%, from $357.40M to $420.30M. Over 5 years (FY 2020 to FY 2025), Amount that if recognized, would affect the effective tax rate or regulatory liability shows an upward trend with a 41.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
Higher values indicate greater potential volatility in future earnings due to tax audit outcomes.
Detailed definition
The portion of unrecognized tax benefits that, if recognized, would directly impact the company's effective tax rate. Th...
Peer comparison
Commonly reported by large-cap firms; peers with stable tax profiles generally maintain lower ratios of this metric relative to total tax expense.
other_unrecognized_tax_benefits_that_would_impact_effect_ff36cbHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $84.50M | $89.00M | $129.50M | $137.40M | $145.20M | $144.90M | $208.50M | $232.20M | $250.40M | $245.40M | $288.70M | $301.60M | $309.30M | $344.50M | $341.40M | $357.40M | $412.10M | $421.60M | $436.60M | $420.30M |
| QoQ Change | — | +5.3% | +45.5% | +6.1% | +5.7% | -0.2% | +43.9% | +11.4% | +7.8% | -2.0% | +17.6% | +4.5% | +2.6% | +11.4% | -0.9% | +4.7% | +15.3% | +2.3% | +3.6% | -3.7% |
| YoY Change | — | — | — | — | +71.8% | +62.8% | +61.0% | +69.0% | +72.5% | +69.4% | +38.5% | +29.9% | +23.5% | +40.4% | +18.3% | +18.5% | +33.2% | +22.4% | +27.9% | +17.6% |
Amount that if recognized, would affect the effective tax rate or regulatory liability at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's amount that if recognized, would affect the effective tax rate or regulatory liability?
- Vertex Pharmaceuticals (VRTX) reported amount that if recognized, would affect the effective tax rate or regulatory liability of $420.30M in Q1 2026.
- How has Vertex Pharmaceuticals's amount that if recognized, would affect the effective tax rate or regulatory liability changed year-over-year?
- Vertex Pharmaceuticals's amount that if recognized, would affect the effective tax rate or regulatory liability increased by 17.6% year-over-year, from $357.40M to $420.30M.
- What is the long-term trend for Vertex Pharmaceuticals's amount that if recognized, would affect the effective tax rate or regulatory liability?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's amount that if recognized, would affect the effective tax rate or regulatory liability has grown at a 41.9% compound annual growth rate (CAGR), from $75.80M to $436.60M.
- What does amount that if recognized, would affect the effective tax rate or regulatory liability mean?
- The amount of uncertain tax benefits that would change the company's effective tax rate if they were ultimately recognized.